Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Promoting excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Mr Roger Hall,
The present status of peripartum cardiomyopathy (PPCM) was reviewed by four world experts. The two most striking features were that a probable pathology call mechanism has begun to emerge in the form of cleavage of prolactin to produce a sub-fraction that appears to have many damaging properties as far as the heart is concerned and that this can be blocked in mice by bromocriptine. Preliminary studies in humans suggest that bromocriptine is a valuable therapeutic agent but more rigorous studies are needed before its place is established. The second striking feature highlighted by the session was the lack of large carefully designed studies to determine the incidence and outcome and also the extent to which recovery of LV function occurs and the risk of recurrence and mortality in future pregnancies. The present consensus is that PPCM is more common in Afro-Caribbean patients with “hotspots” identified in Haiti and Nigeria. The relationship of PPCM to other forms of cardiomyopathy remains to be defined.
An update on peripartum cardiomyopathy